Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic Cancer

NCT04894643 is registered in ClinicalTrials.gov with EBG MedAustron GmbH as lead sponsor.

NCT NCT04894643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04894643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic Cancer
Lead sponsor
EBG MedAustron GmbH
Phase
Not applicable
Overall status
Recruiting
Start date
September 14, 2020
Completion date
December 31, 2027
Enrollment
10 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer, proton therapy